BEKB | BCBE Private Banking:企業の戦略・SWOT・財務分析

◆英語タイトル:BEKB | BCBE Private Banking - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5238
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥44,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥67,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

BEKB | BCBE Private Banking – Strategy, SWOT and Corporate Finance Report
Summary

BEKB | BCBE Private Banking – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

BEKB | BCBE Private Banking offers a wide range of private banking services to high-net-worth individuals (HNWIs have a net worth of US$1 million or more, excluding their primary residence) and wealthy families. Its product offerings include funds, stocks, bonds, cash bonds, structured products and deposit securities. The bank offers key services such as portfolio management services, wealth structuring services, wealth planning, advisory and management services, financial planning, money market services, traditional banking services, inheritance planning and tax planning. BEKB | BCBE Private Banking also offers real estate planning and advisory, pension planning and advisory, property investment and advisory, matrimonial advisory, retirement planning, assets optimization services and succession planning. The bank has a presence in Berner Jura, Solothurn, Seeland, Emmental Oberaargau, Bern Mittelland, Thun, and Berner Oberland regions of Switzerland. BEKB | BCBE Private Banking is headquartered in Bern, Switzerland.

Scope

- Detailed information on BEKB | BCBE Private Banking required for business and competitor intelligence needs
- A study of the major internal and external factors affecting BEKB | BCBE Private Banking in the form of a SWOT analysis
- An in-depth view of the business model of BEKB | BCBE Private Banking including a breakdown and examination of key business segments
- Intelligence on BEKB | BCBE Private Banking’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about BEKB | BCBE Private Banking, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of BEKB | BCBE Private Banking and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess BEKB | BCBE Private Banking as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on BEKB | BCBE Private Banking’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
BEKB | BCBE Private Banking: Company Overview
BEKB | BCBE Private Banking: Overview and Key Facts
BEKB | BCBE Private Banking: Overview
BEKB | BCBE Private Banking: Key Facts
BEKB | BCBE Private Banking: Key Employees
BEKB | BCBE Private Banking: Key Employee Biographies
BEKB | BCBE Private Banking: Major Products and Services
BEKB | BCBE Private Banking: Company History
BEKB | BCBE Private Banking: Locations and Subsidiaries
BEKB | BCBE Private Banking: Key Competitors
BEKB | BCBE Private Banking: Company Analysis
BEKB | BCBE Private Banking: Business Description
BEKB | BCBE Private Banking: SWOT Analysis
BEKB | BCBE Private Banking: SWOT Overview
BEKB | BCBE Private Banking: Strengths
BEKB | BCBE Private Banking: Weaknesses
BEKB | BCBE Private Banking: Opportunities
BEKB | BCBE Private Banking: Threats
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: BEKB | BCBE Private Banking: Key Facts
Table 2: BEKB | BCBE Private Banking: Key Employees
Table 3: BEKB | BCBE Private Banking: Company History
Table 4: BEKB | BCBE Private Banking: Locations and Subsidiaries
Table 5: BEKB | BCBE Private Banking: Key Competitors

★海外企業調査レポート[BEKB | BCBE Private Banking:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Goodwin Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd, is a biological contract development and manufacturing organization that offers antibody drug conjugates, radioimmunoconjugates, and other protein bioconjugates. The organization offers cell culture, purificati …
  • Bayer AG (BAYN):企業の財務・戦略的SWOT分析
    Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Telecom Italia S.p.A.:企業の戦略・SWOT・財務情報
    Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • 4D Molecular Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary 4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evolution, which empowers to create customized gene de …
  • NeuStar Inc:企業の戦略的SWOT分析
    NeuStar Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Myriad Group AG:企業の戦略的SWOT分析
    Myriad Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Dana Brevini SpA:企業の戦略・SWOT・財務情報
    Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kang Stem Biotech Co Ltd (217730):製薬・医療:M&Aディール及び事業提携情報
    Summary Kang Stem Biotech Co Ltd (Kang Stem Biotech) is a biopharmaceutical company that develops stem cell therapeutic products for the treatment of incurable diseases using umbilical cord blood-derived stem cells. The company’s stem cell therapy products include Furestem-AD for treating subacute a …
  • Strategic Resources Inc (STI):企業の戦略的SWOT分析
    Strategic Resources Inc (STI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Bloomberg LP:企業の戦略的SWOT分析
    Bloomberg LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Midsona AB (MSON B):企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), formerly Midelfart Sonesson AB is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food …
  • Etablissementen Franz Colruyt NV (COLR):企業の財務・戦略的SWOT分析
    Etablissementen Franz Colruyt NV (COLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Avadel Pharmaceuticals Plc (AVDL):医療機器:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • Alimentation Couche-Tard Inc. (ATD.B)-石油・ガス分野:企業M&A・提携分析
    Summary Alimentation Couche-Tard Inc. (Couche-Tard) is a retail company that operates an extensive network of convenience stores. The company principally offers food and non-food items as well as transportation fuels. Couche-Tard products include tobacco, alcohol, grocery items, candy, snacks and va …
  • Xhale Inc:製品パイプライン分析
    Summary Xhale Inc (Xhale) is a medical technology company that develops and commercializes patient-centric monitoring solutions for the healthcare industry. The company offers platforms such as SMART and assurance platforms. Its products include therapeutic drug monitoring, metabolic pathway assessm …
  • Ig Group Holdings Plc
    Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ig Group Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ingram Micro Inc:企業の戦略的SWOT分析
    Ingram Micro Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆